Chromoendoscopy and advanced imaging technologies for surveillance of patients with IBD

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Inflammatory bowel disease patients with long-standing colitis have an increased risk of colorectal cancer. The high rate of interval colitis-associated cancers among patients who adhere to a nontargeted, random biopsy surveillance strategy underlies the need for improved methods of early dysplasia detection. Compelling evidence supports the efficacy of chromoendoscopy for increasing the detection rate of dysplasia; however, this technology is currently underutilized in the clinical setting. Other contrast-based technologies-including confocal laser endomicroscopy (Pentax), endocytoscopy, multiband imaging, iscan (Pentax), and molecular-targeted techniques-show promise in the detection of dysplasia in patients with inflammatory bowel disease. The strategies currently available for identifying patients with dysplasia or colitis-associated cancers remain inadequate and need to demonstrate both cost and time efficiency before they can be adopted in communitybased practices.

Original languageEnglish
JournalGastroenterology and Hepatology
Volume8
Issue number12
StatePublished - Dec 1 2012

Fingerprint

Colitis
Technology
Inflammatory Bowel Diseases
Colorectal Neoplasms
Neoplasms
Lasers
Biopsy
Costs and Cost Analysis

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Chromoendoscopy and advanced imaging technologies for surveillance of patients with IBD. / Barkin, Jodie A.; Sussman, Daniel A; Abreu, Maria T.

In: Gastroenterology and Hepatology, Vol. 8, No. 12, 01.12.2012.

Research output: Contribution to journalArticle

@article{26bb469d49bc4e56ae6346bb55c7d736,
title = "Chromoendoscopy and advanced imaging technologies for surveillance of patients with IBD",
abstract = "Inflammatory bowel disease patients with long-standing colitis have an increased risk of colorectal cancer. The high rate of interval colitis-associated cancers among patients who adhere to a nontargeted, random biopsy surveillance strategy underlies the need for improved methods of early dysplasia detection. Compelling evidence supports the efficacy of chromoendoscopy for increasing the detection rate of dysplasia; however, this technology is currently underutilized in the clinical setting. Other contrast-based technologies-including confocal laser endomicroscopy (Pentax), endocytoscopy, multiband imaging, iscan (Pentax), and molecular-targeted techniques-show promise in the detection of dysplasia in patients with inflammatory bowel disease. The strategies currently available for identifying patients with dysplasia or colitis-associated cancers remain inadequate and need to demonstrate both cost and time efficiency before they can be adopted in communitybased practices.",
author = "Barkin, {Jodie A.} and Sussman, {Daniel A} and Abreu, {Maria T}",
year = "2012",
month = "12",
day = "1",
language = "English",
volume = "8",
journal = "Gastroenterology and Hepatology",
issn = "1554-7914",
publisher = "Gastro-Hep Communications, Inc.",
number = "12",

}

TY - JOUR

T1 - Chromoendoscopy and advanced imaging technologies for surveillance of patients with IBD

AU - Barkin, Jodie A.

AU - Sussman, Daniel A

AU - Abreu, Maria T

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Inflammatory bowel disease patients with long-standing colitis have an increased risk of colorectal cancer. The high rate of interval colitis-associated cancers among patients who adhere to a nontargeted, random biopsy surveillance strategy underlies the need for improved methods of early dysplasia detection. Compelling evidence supports the efficacy of chromoendoscopy for increasing the detection rate of dysplasia; however, this technology is currently underutilized in the clinical setting. Other contrast-based technologies-including confocal laser endomicroscopy (Pentax), endocytoscopy, multiband imaging, iscan (Pentax), and molecular-targeted techniques-show promise in the detection of dysplasia in patients with inflammatory bowel disease. The strategies currently available for identifying patients with dysplasia or colitis-associated cancers remain inadequate and need to demonstrate both cost and time efficiency before they can be adopted in communitybased practices.

AB - Inflammatory bowel disease patients with long-standing colitis have an increased risk of colorectal cancer. The high rate of interval colitis-associated cancers among patients who adhere to a nontargeted, random biopsy surveillance strategy underlies the need for improved methods of early dysplasia detection. Compelling evidence supports the efficacy of chromoendoscopy for increasing the detection rate of dysplasia; however, this technology is currently underutilized in the clinical setting. Other contrast-based technologies-including confocal laser endomicroscopy (Pentax), endocytoscopy, multiband imaging, iscan (Pentax), and molecular-targeted techniques-show promise in the detection of dysplasia in patients with inflammatory bowel disease. The strategies currently available for identifying patients with dysplasia or colitis-associated cancers remain inadequate and need to demonstrate both cost and time efficiency before they can be adopted in communitybased practices.

UR - http://www.scopus.com/inward/record.url?scp=84878438116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878438116&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84878438116

VL - 8

JO - Gastroenterology and Hepatology

JF - Gastroenterology and Hepatology

SN - 1554-7914

IS - 12

ER -